TCL Archive NCI Intramural Budget: Well-Funded Labs, High Costs, Or Deceiving Appearances? April 21, 1995
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004